Citing people familiar with the matter, pharmaquest.biz reported that Glaxo will take a 20-per cent stake in Dr. Reddy's Holdings Ltd., a family vehicle that owns 23.2 per cent of the Hyderabad-based Dr Reddy's Laboratories.
As domestic pharma and life science companies aggressively scale up their R&D capabilities to meet the rising demand for clinical research from global majors, they are back in the job market to scout and woo talent with attractive salary packages.
Bafna Pharmaceuticals,shall be focussing mainly on life-style products, the company chariman and managing director, Mahaveer Chand, disclosed, in an exclusive interview with pharmaquest.biz
Union Health and Family Welfare Minister Ghulam Nabi Azad and Gujarat Chief Minister Narendra Modi, on Saturday invited expatriates to invest in the country.
The distance between Big Pharma and the generic drugs business keeps getting narrower. Under a deal with an Indian drugs shop Strides Arcolab, Pfizer will add some 40 off-patent drugs, including many cancer medicines, to the list of products it sells in the U.S. Here’s...
Pharmintech, the international exhibition for technology, materials and services for the processing and packaging of pharmaceutical, personal care and nutraceutical products is scheduled to take place at BolognaFiere from May 12 to 14 2010.
Momentum is building for the early December staging in Mumbai of the third CPhI India and second P-MEC India pharma ingredients, services and technologies event. A combined total of over 600 exhibitors from over 80 countries are expected at the Bombay Exhibition Centre for the...
The fourth edition of the biotechnology investor forum, BioInvest 2009, organized by The Association of Biotechnology Led Entrepreneurs (ABLE) will be held in Mumbai on November 5. The event has been designed to ascertain the future of investment and partnerships in the country’s biosciences space....
Building on 8 years of success serving the pharmaceutical industry, Worldwide Business Research is proud to launch Logipharma as Asia's only dedicated conference for pharmaceutical supply chain professionals.
Companies seem to be hesitating in moving ahead as they wait for further improvements in the global economy. However, Frost & Sullivan believes that the best CEOs are already planning how their businesses will take advantage of the growth opportunities presented by the rebound....
Bangalore-based biopharmaceutical start-up Biovel Lifesciences is looking to exit from the life sciences space and is keen for an early outright buyout. Biovel has been in dialogue with several companies including Ranbaxy, Avesthagen, Shantha Biotechnics Ltd and Orchid Chemicals, it is learnt.
Sanofi-aventis, the world's leading vaccine manufacturer, officially launched the construction of a new Sanofi Pasteur vaccine manufacturing centre in Neuville-sur-Saône, France.
The pharmaceutical and biotechnology industry is in the process of consolidating and down-sizing while trying to maintain R&D productivity. Small and medium-sized companies are trying to make the most of available opportunities in niche segments.
Last year, the Biotech industry as a whole achieved much better performance than the market. Both the NASDAQ Biotech Index and AMEX Biotech Index outperformed all three major market indices (Dow Jones Industrial Average, NASDAQ Composite and S&P 500) in a large margin. The...
Lupin Ltd, one of the top five domestic pharmaceutical companies, plans to revamp its drug research programme and foray into novel biotech and reverse engineering of biotech drugs (or biosimilars).
The pharmaceutical market in Russia managed to grow by more than 25% in 2009 despite the economic downturn. But domestic producers are still losing out to their foreign rivals.
In one stroke, Swiss pharma giant Novartis AG could break into the league of top five players in the Rs 600-crore plus Indian eyecare market from its current position at 13, if its takeover of Alcon goes through seamlessly and eventually results in integration of...
Strides Acrolabs, which struck a drug supply deal with Pfizer on Wednesday, said it is discussing similar drug supply deal for niche therapeutics areas with global drug pharma companies. The Bangalore-based company will start getting part of the money from its deal with Pfizer this...
Seattle Genetics just scored a potentially big licensing deal with Big Pharma. The Bothell biotech company announced a collaboration agreement with GlaxoSmithKline that will give Glaxo rights to use its antibody-drug conjugate technology.
1.Indian Institute of Toxicology - Indian Institute of Toxicology (IIT) is one of the pioneers, independent Contract Research Organization (CRO) engaged in toxicology and has been in the business for the past 25 Years. The institute is committed to excellence, which is borne out of a State-of-art infrastructure & technical skills in the field of Toxicology Studies.... [English]-[French]-[Spanish]
EMERGING MARKETS
Lilliputs keep cropping up here and there, but can Gulliver be ignored?
Many shifting focus to emerging economies in struggle to stay afloatMajor Japanese pharmaceutical makers are expediting projects to construct plants and expand sales channels in emerging economies, such as China and India.
After East Europe and Mexico, Daiichi Sankyo, which bought out Ranbaxy Labs Ltd last year, is all set to leverage the latter’s marketing and distribution strength in six countries of Africa. This is the third instance in the last four months where Ranbaxy is helping...
Pharma major Ranbaxy Laboratories today said it has launched a new dermatological product Lulifin in the Indian market. This follows a strategic in-licensing agreement with Summit Pharmaceuticals International Corporation, Japan, Ranbaxy said.
DR REDDY’S Laboratories plans to buy brands in Russia and introduce new products in India as it plans to scale up businesses in key emerging markets, a top company executive said.
Brand ambassador Kajol Devgan promotes the kiss of good health. Expanding its footprint in India, Yakult Danone India (P) Ltd. announced its expansion by launching Yakult, a global probiotic health drink in the city today.
Indian Pharma Companies Eye High Potency API Market Pie The Indian Active Pharmaceutical Ingredient (API) Industry is fast developing though many challenges exist as it....[English]-[French]-[Spanish]
Indian Biogenerics Firms Poised to Storm Western Markets With blockbuster first-generation biotherapeutics developed in the West are losing patent protection, Indian biopharma...[English] [French] [Spanish]
CLINICAL TRIALS
Pharma major Dr Reddy’s Laboratories Ltd., (DRL), on Monday, announced results from the first phase III trials of its chemical entity, Balaglitazone, an insulin sensitizer used in the treatment of diabetes.
GE Healthcare announced the launch of FTA DMPK cards for the collection and storage of blood samples for use in pharmacokinetic and toxicokinetic (PK/TK) studies.
Ecron Acunova, a full-service clinical research organization (CRO), with offices across Europe, India and the US, has strengthened its Eastern European presence further by opening a new office in Moscow. Galyna Andriyko will lead the development of the Russian office operations.
In what seems to be an alarming situation for the national health, India ranks highest in the list of Tuberculosis (TB) inflicted countries worldwide, as unveiled by the Union Ministry of Chemicals and Fertilizers.
Launches RECOMBINATE a genetically engineered, non-plasma-derived FVIII bringing advanced care to people with Hemophilia in India. Baxter India Private Limited, a wholly owned subsidiary of Baxter International Inc., the global leader in Hemophilia care today announced the launch of RECOMBINATE in India. RECOMBINATE, a genetically engineered...
US-based Zydus Pharmaceuticals, a subsidiary of Zydus Cadila, has received final approval from the US Food and Drug Administration (USFDA) to market Ramipril tablets, in the strengths of 1.25 mg, 2.5 mg, 5 mg and 10 mg.
The strategy of the Hyderabad-based pharma major Dr Reddy's Laboratories' (DRL) to approach the US market with a series of gambles rather than on one major upside is paying dividends.
.gif)
Indian Pharma Companies Eye High Potency API Market Pie
Indian Biogenerics Firms Poised to Storm Western Markets
